130 related articles for article (PubMed ID: 10739887)
1. Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.
Bagli M; Papassotiropoulos A; Knapp M; Jessen F; Luise Rao M; Maier W; Heun R
Neurosci Lett; 2000 Apr; 283(2):109-12. PubMed ID: 10739887
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
Shibata N; Ohnuma T; Takahashi T; Baba H; Ishizuka T; Ohtsuka M; Ueki A; Nagao M; Arai H
Am J Med Genet; 2002 May; 114(4):436-9. PubMed ID: 11992567
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
[TBL] [Abstract][Full Text] [Related]
5. Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients.
Seripa D; Matera MG; Dal Forno G; Gravina C; Masullo C; Daniele A; Binetti G; Bonvicini C; Squitti R; Palermo MT; Davis DG; Antuono P; Wekstein DR; Dobrina A; Gennarelli M; Fazio VM
Neurobiol Aging; 2005 Apr; 26(4):455-64. PubMed ID: 15653174
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.
Licastro F; Grimaldi LM; Bonafè M; Martina C; Olivieri F; Cavallone L; Giovanietti S; Masliah E; Franceschi C
Neurobiol Aging; 2003 Nov; 24(7):921-6. PubMed ID: 12928051
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
8. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease.
He MX; Yang WL; Zhang MM; Lian YJ; Hua HY; Zeng JS; Zhang LR
Neurol Sci; 2010 Apr; 31(2):165-8. PubMed ID: 19957198
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.
Ramos EM; Lin MT; Larson EB; Maezawa I; Tseng LH; Edwards KL; Schellenberg GD; Hansen JA; Kukull WA; Jin LW
Arch Neurol; 2006 Aug; 63(8):1165-9. PubMed ID: 16908746
[TBL] [Abstract][Full Text] [Related]
10. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
Zhao J; Liu P; Hua L; Yang X; Zeng Z; Li X; Wang S; Liu Y; Liu Y; Wang Y
Exp Gerontol; 2020 Mar; 131():110813. PubMed ID: 31874191
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease.
Depboylu C; Du Y; Müller U; Kurz A; Zimmer R; Riemenschneider M; Gasser T; Oertel WH; Klockgether T; Dodel RC
Neurosci Lett; 2003 May; 342(1-2):132-4. PubMed ID: 12727335
[TBL] [Abstract][Full Text] [Related]
13. Association between interleukin 6 gene haplotype and Alzheimer's disease: a Brazilian case-control study.
Rasmussen L; Delabio R; Horiguchi L; Mizumoto I; Terazaki CR; Mazzotti D; Bertolucci PH; Pinhel MA; Souza D; Krieger H; Kawamata C; Minett T; Smith MC; Payão SL
J Alzheimers Dis; 2013; 36(4):733-8. PubMed ID: 23666170
[TBL] [Abstract][Full Text] [Related]
14. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease.
Depboylu C; Lohmüller F; Gocke P; Du Y; Zimmer R; Gasser T; Klockgether T; Dodel RC
Dement Geriatr Cogn Disord; 2004; 17(3):170-3. PubMed ID: 14739540
[TBL] [Abstract][Full Text] [Related]
15. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
Ma SL; Tang NL; Lam LC; Chiu HF
Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease--preliminary report.
Paradowski B; Celczyńska D; Dobosz T; Noga L
Neurol Neurochir Pol; 2008; 42(4):312-5. PubMed ID: 18975235
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
19. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Du Y; Dodel RC; Eastwood BJ; Bales KR; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans RM; Hake A; Gasser T; Oertel WH; Griffin WS; Paul SM; Farlow MR
Neurology; 2000 Aug; 55(4):480-3. PubMed ID: 10953177
[TBL] [Abstract][Full Text] [Related]
20. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
